These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 13753033)

  • 1. [On the clarification of the structure and synthesis of bradykinin].
    KONZETT H
    Wien Klin Wochenschr; 1961 Feb; 73():119-20. PubMed ID: 13753033
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthetic bradykinin: its biological identity with natural pure trypsin bradykinin.
    KONZETT H; STUERMER E
    Nature; 1960 Dec; 188():998. PubMed ID: 13753030
    [No Abstract]   [Full Text] [Related]  

  • 3. Isolation and molar activity of human bradykinin.
    HAMBERG U
    Biochem Biophys Res Commun; 1962 Apr; 7():95-100. PubMed ID: 13904060
    [No Abstract]   [Full Text] [Related]  

  • 4. Bradykinin from total bovine plasma.
    HAMBERG U
    Biochim Biophys Acta; 1959 Jul; 34():135-46. PubMed ID: 14399201
    [No Abstract]   [Full Text] [Related]  

  • 5. Cerebrospinal fluid and bradykinin release.
    HAMBERG U
    Biochem Pharmacol; 1960 May; 3():169-71. PubMed ID: 14399203
    [No Abstract]   [Full Text] [Related]  

  • 6. [Identification of a "spontaneous" peptide formed from serum globulin with bradykinin].
    HABERMANN E; OKON ME
    Hoppe Seylers Z Physiol Chem; 1961 Nov; 326():171-3. PubMed ID: 13903390
    [No Abstract]   [Full Text] [Related]  

  • 7. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid.
    Charlesworth MC; Young CY; Miller VM; Tindall DJ
    J Androl; 1999; 20(2):220-9. PubMed ID: 10232657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bradykinin, Information on its structure, synthesis and physiologic-pharmacological bases].
    CERLETTI A; STUERMER E
    Dtsch Med Wochenschr; 1961 Apr; 86():678-83. PubMed ID: 13691972
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bradykinin. Structure--synthesis--physio-pharmacological basis].
    KONZETT H; STURMER E; CERLETTI A
    Clin Ter; 1961 Jan; 20():21-34. PubMed ID: 13753031
    [No Abstract]   [Full Text] [Related]  

  • 10. Antagonistic effect of kallikrein against bradykinin.
    Ercan ZS; Türker RK; Torunoglu M
    Arzneimittelforschung; 1978; 28(10):1712-4. PubMed ID: 582675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biochemical remarks on therapy with kallikrein and kallikrein inactivator].
    WERLE E
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1963; 303():5-10. PubMed ID: 14000005
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma kallikrein: the bradykinin-producing enzyme.
    Björkqvist J; Jämsä A; Renné T
    Thromb Haemost; 2013 Sep; 110(3):399-407. PubMed ID: 23846131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THE BASIS OF ITCHING.
    CORMIA FE
    J Pediatr; 1965 Jan; 66():SUPPL:207-9. PubMed ID: 14246573
    [No Abstract]   [Full Text] [Related]  

  • 14. The synthesis of a biologically active decapeptide having the structure proposed for kallidin II.
    NICOLAIDES ED; DEWALD HA; McCARTHY DA
    Biochem Biophys Res Commun; 1961 Nov; 6():210-2. PubMed ID: 14479512
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of kallikrein-kininogen system in insulin-stimulated glucose transport after muscle contractions.
    Dumke CL; Kim J; Arias EB; Cartee GD
    J Appl Physiol (1985); 2002 Feb; 92(2):657-64. PubMed ID: 11796678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration by kallikrein and bradykinin of the conversion of angiotensin I to angiotensin II in the isolated perfused rat lung.
    Ercan ZS; Bor NM; Torunoğlu M; Türker RK
    Arzneimittelforschung; 1982; 32(1):30-1. PubMed ID: 6174131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Separation and purification of pancreatic kallikrein].
    HABERMANN E
    Hoppe Seylers Z Physiol Chem; 1962 Jun; 328():15-23. PubMed ID: 13903392
    [No Abstract]   [Full Text] [Related]  

  • 18. [Differentiation between kallikrein and kallikrein elements by means of antiserum and diisopropylfluorophosphate].
    HABERMANN E
    Hoppe Seylers Z Physiol Chem; 1962 Jun; 328():24-30. PubMed ID: 13903391
    [No Abstract]   [Full Text] [Related]  

  • 19. Human decidua is a target tissue for bradykinin and kallikrein: phosphoinositide hydrolysis accompanies arachidonic acid release in uterine decidua cells in vitro.
    Schrey MP; Holt JR; Cornford PA; Monaghan H; al-Ubaidi F
    J Clin Endocrinol Metab; 1992 Feb; 74(2):426-35. PubMed ID: 1309839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bradykinin activity of some synthetic peptides with only slight structural resemblance to natural bradykinin.
    TRITSCH GL; WOOLLEY DW
    Nature; 1960 Apr; 186():76-7. PubMed ID: 13839411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.